Objectives-Comparison of the suitability of two minor urinary metabolites of benzene, trans,trans-muconic acid (tt-MA) and S-phenylmercapturic acid (S-PMA), as biomarkers for low levels of benzene exposure. Methods-The sensitivity of analytical methods of measuring tt-MA and S-PMA were improved and applied to 434 urine samples collected from 188 workers in 12 studies in different petrochemical industries and from 52 control workers with no occupational exposure to benzene. In nine studies airborne benzene concentrations were assessed by personal air monitoring. Results-Strong correlations were found between tt-MA and S-PMA concentrations in samples from the end of the shift and between either of these variables and airborne benzene concentrations. It was calculated that exposure to 1 ppm (8 hour time weighted average (TWA)) benzene leads to an average concentration of 1'7 mg tt-MA and 47 jg S-PMA/g creatinine in samples from the end of the shift. It was estimated that, on average, 3 9%/6 (range 1.90/o-7.3%) of an inhaled dose of benzene was excreted as tt-MA with an apparent elimination half life of 5*0 (SD 2.3) hours and 0*11% (range 0-050/%0-26%) as S-PMA with a half life of 9 1 (SD 3.7) hours. The mean urinary S-PMA in 14 moderate smokers and 38 non-smokers was 3*61 and 1*99 uglg creatinine, respectively and the mean urinary tt-MA was 0 058 and 0 037 mglg creatinine, respectively. S-PMA proved to be more specific and more sensitive (P = 0-030, Fisher's exact test) than tt-MA. S-PMA, but not tt-MA, was always detectable in the urine of smokers who were not occupationally exposed. S-PMA was also detectable in 20 of the 38 nonsmokers from the control group whereas tt-MA was detectable in only nine of these samples. The inferior specificity of tt-MA is due to relatively high background values (up to 0'71 mglg creatinine in this study) that may be found in non-occupationally exposed people. Conclusions-Although both tt-MA and S-PMA are sensitive biomarkers, only S-PMA allows reliable determination of benzene exposures down to 0 3 ppm (8 h TWA) due to its superior specificity. Because it has a longer elimination half life S-PMA is also a more reliable biomarker than tt-MA for benzene exposures during 12 hour shifts. For biological monitoring of exposure to benzene concentrations higher than 1 ppm (8 h TWA) tt-MA is also suitable and may even be preferred due to its greater ease of measurement. (Occup Environ Med 1995;52:611-620) 
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(Occup Environ Med 1995;52:611-620) Keywords: benzene; biomarkers; S-phenylmercapturic acid; transtrans-muconic acid The main metabolites that can be found in urine after exposure to benzene are phenol and its conjugates.' As a consequence, total urinary phenol has been used as a biomarker for occupational exposure to benzene for a long time. Its use, however, is limited to benzene concentrations over 5 ppm (16 mg/M3) as an 8 hour time weighted average (TWA) because a substantial background of phenol may be found in non-exposed people due to dietary habits. In many countries, however, the occupational limit concentration for airborne benzene will be, or has already been, lowered to 1 ppm (8 h TWA). In some countries even lower values have been adopted (Sweden 0 5 ppm) or proposed (United States 0 3 ppm). As a consequence new biomarkers are needed. Although measurement of benzene itself either in blood or exhaled air is both highly specific and sensitive,23 urinary measurements are preferred in occupational medicine as collection of urine is not only non-invasive but also easily performed even at distant working locations. Over the past few years two minor urinary metabolites of benzene have been introduced as new biomarkers for determination of benzene exposure:
trans,trans-muconic acid (tt-MA, 2,4-hexadi- 1 and 12 samples for study 2). In the urinary samples of two operators from study 1 (eight samples) and three operators from study 2 (seven samples) who had airborne exposure to benzene higher than 1 5 ppm (12 h TWA) urinary phenol concentrations were also measured.
Study 3 was performed on 16 people engaged in activities before shut down. Only five people were involved for one day, the other 11 people were involved for two to four consecutive 12 hour shifts. Personal air sampling was carried out on these 11 people as described for study 1 . All 16 people provided urine samples before and after the shift on each working day and nine of the 11 people who worked more than one day provided an additional urine sample 12 hours after the end of the last shift. One worker did not provide a sample at the end of the shift on day 3. Both S-PMA and u-MA were determined in all 83 urine samples. Also phenol was measured in 18 urine samples of workers with airborne benzene concentrations higher than 2 mg/M3 (12 h TWA).
Study 4 was performed on four consecutive days (12 hour shifts) on four people involved in routine small maintenance operations.
Personal air monitoring was carried out as described for study 1 (1-38)
Four studies were carried out during routine operations in chemical plants.
Study 5 In all studies, urine samples were collected in polythene bottles and acidified to pH 2 with 6 M hydrochloric acid on site. Stability studies of tt-MA, S-PMA, and phenol in urine had shown that under these conditions concentrations did not change if stored at room temperature or 40C for at least a month.9 13 The samples were transported to the Shell Biomedical Laboratory, Rotterdam, for measurement of urinary benzene metabolites and creatinine. Urinary creatinine was measured to adjust for the variations in concentration of urine samples due to differences in fluid intake between workers. Urinary creatinine was previously shown to provide a good correction for spot samples if 24 hour samples could not be collected'3 and it concomitantly allows adjustment for the variable dilution introduced by the acidification of the samples. Personal air sampling and benzene analyses were performed by local staff.
MEASUREMENT OF URINARY METABOLITES
The measurement of phenol and creatinine have been described previously.'3 The S-PMA was also measured as described previously,'3 but as an internal standard deuterium labelled S-PMA was used instead of S-benzylmercapturic acid (S-BMA). The S-
[pentadeuterophenyl]mercapturic acid (d5-S-PMA) was synthesised from ring-d5 aniline with the Gattermann reaction according to RumpPf6 and was recrystallised twice from ethanol with water. The use of d5-S-PMA as an internal standard allowed a limit of detection of 1 jg/l. A series of urine samples were pooled, spiked with S-PMA at two different concentrations, acidified, and stored frozen at -20'C. In all runs a set of samples from this urine pool was analysed to check the reproducibility of the method. The coefficient of variation between different runs (n = 42) was 8-9% for the pool with 28 pug S-PMA/l and 6d1% for the pool with 104 pug S-PMA/l. The coefficient of variation of replicate analyses (n = 10) was 2 5% and 3 5% at spiked concentrations of 13-1 and 50 1 pg S-PMA/l, respectively. With this procedure up to 30 urine samples could be analysed in one day.
The measurement of tt-MA was essentially that of Ducos et al. 5 In our hands, this method gave non-reproducible recoveries. It seemed that the recovery was dependent on both the urinary pH and the brand of the quaternary ammonium ion exchange resin (SAX columns) used. With some brands poor recoveries were obtained with slightly acidic urines. Therefore, the urine samples were brought to pH [7] [8] [9] [10] by addition of 35% (w/v) aqueous sodium hydroxide solution before the sample was cleaned up by solid phase extraction. An aliquot of 1I00 ml of urine was subsequently passed through a SAX column. The column was washed with 3 ml 1 % (v/v) aqueous acetic acid and the tt-MA eluted with 4 ml 10% (v/v) aqueous acetic acid into calibrated tubes and the volume was made up to 5 0 ml with purified water. Aliquots (20 pl) of this solution were analysed by high performance liquid chromatography (HPLC) with UV (A = 259 nm) detection (Hewlett Packard 1084B) at 20°C with a 100 x 2-1 mm stainless steel column with Spherisorb 5 ODS-2 as the immobile phase and 20% (v/v) methanol in 1% (v/v) aqueous acetic acid as the mobile phase. The flow rate was set at 1 ml/min. For calibration, a series of tt-MA standards in fresh control urine samples were analysed together with the urine samples. Alkalisation of the urine samples before the solid phase extraction greatly improved the reproducibility: optimum recoveries (invariably over 95%) were obtained if the urinary pH ranged from 7 to 10. A more effective clean up was a side effect of the alkalisation of the samples, which lowered the detection limit to 0-01 mg/l. The coefficient of variation of replicate analyses (n = 10) was 3 2% at a spiked concentration of 0-64 mg/l and 0-4% at a spiked concentration of 5-55 mg/l. The area under the curve(1 2) = 0.0625 x ((c -C2) x t2 -t,))/(ln(c,) -ln(C2)), where 0-0625 is the average urinary volume (1/h), c, denotes the concentration of metabolite (either tt-MA or S-PMA) in the urine sample collected at time t, (end of the shift) and c2 the concentration of metabolite at time t2 (next morning) during the elimination phase (c, > c2). The absorbed benzene dose was estimated with the formula: dose = 0-47 x C x V, where 0 47 is the fraction of benzene that is retained upon inhalation,'8 C denotes the airborne concentration (mg benzene/m3) and V the average respiratory volume (1 25 m3/h).
Both for tt-MA and S-PMA apparent urinary elimination rate constants were calculated from workers who had provided urine samples at the beginning and end of a shift on at least two consecutive days. For the calculation of the apparent elimination rate constants (k-) it was assumed that the absorption was completed and that first order elimination kinetics were obeyed during the collection period. The following formula was used:
ln(c2/c,) = -ke x (t2 -t.), where c, denotes the concentration of metabolite (either tt-MA or S-PMA) in the urine sample collected at the end of the shift at time t, and c2 the concentration of metabolite at the beginning of the next day shift at time t2. Occasionally, when the absorption phase was not yet completed at the end of the shift (t,), c, was higher than cl. In these cases k, was calculated from the decline in metabolite during the same shift but only if there was no detectable exposure to benzene. In these cases c, denotes the concentration of metabolite (0 57) ,ug/g creatinine. S-PMA was present at detectable concentrations in the urine of all smokers and in 20 of the 38 non-smokers. This showed the superior sensitivity (P = 0-030, Fisher's exact test) of S-PMA over tt-MA, for which urinary concentrations were below the detection limit in three smokers and 29 non-smokers. Although the delectability (yes, no) of both biomarkers was strongly correlated with smoking (yes, no) (P < 0000 1, Fisher's exact test), multivariate regression analysis disclosed no correlation with the number of cigarettes smoked and either S-PMA or tt-MA.
URINARY tt-MA AND S-PMA IN OCCUPATIONALLY EXPOSED POPULATIONS
The table gives an overview of the results obtained in the 12 studies in industrial workers with potential exposure to benzene. The high airborne benzene concentrations measured in studies 1, 2, and 3 (up to 19-2 mg/m3) did not reflect normal operations but peak exposures measured in selected operators with relatively high potential exposure to aromatic compounds during special maintenance operations on gas production platforms. Both tt-MA and S-PMA excretion increased over the shift and reflected the airborne benzene exposure. During routine operations (study 4) benzene exposure was usually far below 1 ppm (3-25 mg/m3) but, nevertheless, increases in both tt-MA and S-PMA were found. In the urine samples provided by operators with relatively high benzene exposures (> 0-5 ppm) phenol was also measured. It seemed that phenol correlated well with both tt-MA and S-PMA in operators with low background values of phenol (< 5 mg/g creatinine). The very high exposures in studies 5 and 6 (up to 211 mg/m3) also represented selected operators who had incidental peak exposures due to accidental spillage during maintenance operations. In 68% of the samples collected in study 5 phenol measurements were also carried out. The correlation of phenol with tt-MA as well as with S-PMA was rather poor: there were several increased values of phenol ( ) 50 mg/g creatinine) without concurrent exposure or substantially increased tt-MA or S-PMA, and occasionally phenol was not increased (s< 5 mg/g creatinine) although both tt-MA and S-PMA were clearly increased (tt-MA ) 1 mg/g creatinine or S-PMA > 45 ,ug/g creatinine). During operations in oil refineries with aromatic plants (studies 9 and 10) exposures were generally well below 1 ppm. In all cases distinct increases in both tt-MA and S-PMA were found in the samples collected at the end of the shift compared with those collected at the beginning.
Time (h) Figure 1 Urinay excretion of tn-MA and S-PMA in two workers (A and B) after exposure to benzene on eight consecutive days.
URINARY EXCRETION OF tt-MA AND S-PMA OVER TIME Figure 1 depicts the urinary excretion v time plots from the two workers from study 8, who were biologically monitored for eight consecutive days. The results of the personal air measurements for benzene are shown in the graphs as bars. The first worker (A) was exposed to relatively high concentrations of benzene up to 5-2 mg/M3 (1-6 ppm) on the third working day. The second worker was exposed to much lower concentrations of benzene: the highest exposure was recorded on the sixth working day and was 1-63 mg/m3 (05 ppm). It is clear, especially from the excretion profile of the more highly exposed worker, that the excretion of tt-MA and S-PMA follow roughly the same pattern and that the excretion of both metabolites reflect the exposure to benzene. It is also clear that, due to the shorter apparent half life of tt-MA than S-PMA, tt-MA returns to baseline values at the beginning of the next shift after exposures up to 1 ppm whereas S-PMA tends to accumulate at exposures over about 05 ppm.
TOXICOKINETICS OF tt-MA AND S-PMA
Twenty nine workers provided urine samples on at least two consecutive days. For 27 workers values for the apparent urinary excretion constants could be calculated from 52 and 38 data points for tt-MA and S-PMA, respectively. The median k, for tt-MA was 0-136 1/h and for S-PMA 0077 1/h. These values correspond to median apparent elimination half lives of 5-1 (mean (SD) 5 0 (2 3)) hours and 9 0 (9-1 (3 7)) hours, respectively. For 14 workers sufficient personal air monitoring and biological monitoring data were collected to allow an estimation of the urinary excretion of tt-MA and S-PMA as a percentage of the dose of inhaled benzene. The average percentage of the dose that was excreted as tt-MA was 3 9% (range 1-9%-7-3%) and as S-PMA was 0-1 1% (range 0 05%-0 26%).
RELATION BETWEEN DIFFERENT URINARY METABOLITES OF BENZENE
In fig 2 the tt-MA concentrations were plotted against the S-PMA concentration in the same urine sample, both after logarithmic transformation, for all 188 workers from studies 1-12. If for a worker more than one set of values was measured, the set of values corresponding to the highest airborne benzene concentration was chosen, or if no air measurements were performed, the set with the highest values. A highly significant correlation between tt-MA and S-PMA was found (r = 0 795, P < 0-0001). Nevertheless, some deviations were found. In some cases where no exposure to benzene had occurred, relatively high concentrations of tt-MA (up to 0 71 mg/g creatinine) were measured in the urine (without high concentrations of S-PMA: < 1 yg/g creatinine).
An exceptional finding was made in study 12. The two workers involved in this study carried out the same job in close vicinity of each other. Figure 3 shows the results of the personal air monitoring and the values of S-PMA and tt-MA. It seems that on the first day the airborne concentrations of benzene are more or less identical for both men. One of the workers (closed symbols) excreted both S-PMA and tt-MA in concentrations that match the concentration of benzene in air. In the urine of the other man tt-MA was found as expected, but surprisingly no increases in S-PMA were found. From the medical records it seemed that this worker was treated for epilepsy with high doses of carbamazepine, a known inducer of hepatic mixed function oxidases. The relation between airborne benzene exposures (8 h TWA) and urinary S-PMA and tt-MA concentrations was examined in samples collected at the end of the shift from 58 workers in studies 5, 6, 10, and 12. The actual working hours in these studies were close to eight hours. Data from workers who had worn respiratory protection during the monitoring period were excluded from the statistics. In cases where more than one data point had been generated for a worker, the data point with the highest airborne benzene concentration was used for the linear regression analysis. Highly significant correlations (P < 0-0001) were found for both S-PMA and tt-MA (fig 4) . The equations for the regression lines were: urinary tt-MA (mg/g creatinine) -0 900, r = 0 959 From the regression lines it was calculated that after an 8 h TWA benzene exposure of 1 ppm (3-25 mg/M3), the average concentration in a urine sample collected at the end of the shift would be 47 ug S-PMA/g creatinine and 1-74 mg tt-MA/g creatinine. The corresponding 95% confidence intervals (95% CIs) for the group means are 34-61 ,ug S-PMA/g creatinine and 1-2-2-2 mg tt-MA/g creatinine, respectively.
In the other studies where air measurements were made (1-4 and 8) the workers were on duty in 12 hour shifts. A separate regression analysis was made with the data collected in these studies. Again, only one set of data was included for each worker and data collected while respiratory protection was worn were excluded. Also, data collected during operations with apparent dermal exposure, as recorded by the occupational hygienist, were excluded from the analyses. Finally, the following regression equations (fig 5) , with highly significant correlations (P < 0-0001), were obtained by analysing data sets from 28 workers: In the past few years, tt-MA and S-PMA, two minor metabolites of benzene, have been proposed to replace phenol as biomarkers of exposure to benzene. These metabolites can both be measured in urine, which in our view is a prerequisite for good biological monitoring. Since its introduction in 1985, improved methods have been published for the measurement of urinary tt-MA by Inoue and co-workers4 who claimed to be able to detect benzene exposure to 6-7 ppm and by Ducos and co-workers5 6 who improved Inoue's method by increasing the sensitivity, which allowed biological monitoring of benzene exposure down to 1 ppm (8 h TWA). Recently, we published an improvement of the method for the determination of S-PMA as proposed by Stommel and coworkers'2 that allows routine biological monitoring of exposure to benzene as low as 0 3 ppm (8 h TWA).'3 This paper reports the results of 12 separate investigations where measurements of both urinary tt-MA and S-PMA were applied.
The methods were compared for sensitivity, specificity, and ease of operation, to get a better insight into their suitability for routine biological monitoring of industrial exposure to low concentrations of benzene. To a limited extent urinary phenol measurements were also performed to enable a comparison of this established biological monitoring method with the more recent biological monitoring methods.
We found that measurement of tt-MA as described by Ducos MA from the columns seemed to be dependent on the pH of the urine sample.
Alkalisation of the samples to a pH of 7 to 10 gave optimum recoveries that were invariably over 95%. It seemed that the solid phase extraction was more efficient at a higher pH, which resulted in cleaner extracts and a lower limit of detection (0-01 mg/l). Recently, this same favourable effect of alkalisation was also reported by Lee and coworkers who added 2 volumes of a TRIS buffer (pH 10) to the urine samples before the solid phase extraction. 9 Overall, the method proved to be simple, straightforward, and robust, which resulted in small variation coefficients within and between runs.
In the method used for the determination of S-PMA, the internal standard S-BMA was replaced by deuterated S-PMA in the present study for two reasons. The first reason was to improve the sensitivity and reliability of the method. In our previous report it was stated that the limit of detection varied from 1 to 5 jug/l, depending mainly on matrix effects.'3 It seemed that in urine specimens with a high specific gravity, S-PMA concentrations lower than about 5 ,ug/l could in certain cases not be attributed with certainty. With deuterated S-PMA as the internal standard this problem was solved and a limit of detection of 1 ,ug/l could be guaranteed.
The second reason was that toluene was recently reported to be metabolised in humans to S-BMA. 19 20 In many industrial processes with a risk of exposure to benzene co-exposure to toluene may occur and biotransformation of toluene to S-BMA might interfere with its use as an internal standard.
In some preliminary studies we could indeed identify small amounts of S-BMA (up to 4 0 ,ug/l) in 10 workers exposed to low concentrations of toluene (up to 5-3 ppm, 8 h TWA) (unpublished observations). We found in this as well as in our previous studies'3 that only 0-11% of inhaled benzene is metabolised to S-PMA and although toluene is probably metabolised even less to S-BMA, there might still be serious interference in some cases as the airborne concentrations of toluene may exceed those of benzene by one or two orders of magnitude in many industrial operations.
The problem of interference due to co-exposure to toluene may also be overcome with a halogenated phenylmercapturic acid, such as S-4-fluorophenylmercapturic acid, as the internal standard,'2 1" but this will not solve the loss of sensitivity due to matrix effects. Because of the increased sensitivity of the measurement of S-PMA, the benzene uptake due to cigarette smoking was detectable in all 14 smokers from the control group (mean (SEM) 3-61 (0-57) ,ug/g creatinine). In 20 out of the 38 non-smokers of the control group S-PMA could also be detected albeit in much lower concentrations (1 99 (0 32) ,ug/g creatinine). The sensitivity of the tt-MA measurement was too low to allow detection of tt-MA in most non-smokers and some smokers in the control group. The concentrations of tt-MA in the smokers (0-058 (0-013) mg/g creatinine) and non-smokers (0 037 (0-16) mg/g creatinine) were relatively low compared with the results of a recent study on tt-MA conducted in Singapore where values of 0-19 and 0-14 mg/g creatinine were found in 35 smokers and 23 non-smokers, respectively.9 Although the same detection limit for tt-MA was reported as in our study, tt-MA was detectable in all smokers and almost half of the non-smokers. The investigators thought that their relatively high background values were due to environmental pollution. In another recent study values of 0-29 and 0 09 mg tt-MA/g creatinine were measured in 42 smokers and 42 non-smokers, respectively. Although the smokers in these two studies seemed to consume larger quantities of cigarettes than the moderate smokers in our control group, there was no correlation between the number of cigarettes smoked and excretion of tt-MA,9 but a weak correlation was found between excretion of tt-MA and urinary cotinine concentrations.
The toxicokinetics, based on spot samples, were studied for both tt-MA and S-PMA. Despite the fact that only spot samples were collected and that tl/2 of tt-MA is considerably shorter than that of S-PMA a good correlation was found between urinary concentrations of tt-MA and S-PMA (fig 2) . Also good correlations between benzene in air and S-PMA as well as tt-MA were found (figs 4 and 5). The 95% CIs in these figures as well as the correlation coefficients for the regression lines indicate that the reliability of tt-MA and S-PMA as biomarkers for benzene exposure during eight hour shifts are almost identical. It is obvious, however, that the reliability of tt-MA as a biomarker for benzene exposure during 12 hour shifts is much less than for S-PMA, which is totally due to its shorter elimination half life.
From these correlations it follows that exposure to 1 ppm benzene (8 h TWA) will lead to an average excretion of 1 74 mg tt-MA/g creatinine and 47 ug S-PMA/g creatinine in urine samples collected at the end of the shift. These values seem to be confirmed by the regression equation in fig 2, from which it can be calculated that 47 pg S-PMA/g creatinine corresponds to 1 69 mg tt-MA/g creatinine. The value of 47 Pg/g creatinine for S-PMA also agrees well with the findings from our previous studies, where a similar value was found.'3 Bechtold and coworkers found in a group of 14 Chinese female workers that exposure to 4-4 ppm benzene (8 h TWA) led to an average excretion of 6-2 mg tt-MA/g creatinine in urine samples collected at the end of the shift. This matches our results extremely well as according to the regression line obtained with our data such an exposure would lead to excretion of 6-4 mg/g creatinine. Our findings are also in good agreement with two other studies in 23 French and 38 Belgian male workers where it was found that exposure to 1 ppm benzene (8 h TWA) corresponded to 1 mg tt-MA/16 and 1-4 mg n-MA/g creatinine,'0 respectively.
In some cases skin contact with liquids containing benzene was reported by the industrial hygienist. The personal air monitoring data and the concentrations of tt-MA and S-PMA measured in the urine collected at the end of the shift strongly suggest that in these cases rather extensive dermal uptake of benzene had taken place. For example, during the replacement with bare hands of a plunger in a skimmerpump for natural gas condensate in study 1, an airborne benzene concentration of 19-2 mg/M3 was measured as a 12 h TWA. In the urine collected at the end of the shift mg tt-MA and 798,ug S-PMA/g creatinine were measured. According to the regression equations for the relation between airborne benzene (12 h TWA) and the urinary metabolites in urine at the end of the shift, the concentration tt-MA and S-PMA would indicate exposure to 25-2 and 41-0 mg benzene/ml, respectively. Although the value for tt-MA is just inside the 95% CI for individual results, it is extremely unlikely (P < 0-001) that the result for S-PMA is solely due to inhalation exposure.
The present study was undertaken to compare the suitabilities of tt-MA and S-PMA for biological monitoring of low level benzene exposure. Our results confirm previous findings by ourselves and others that the measurements of both urinary tt-MA and S-PMA are sensitive tests for monitoring exposure to low concentrations of benzene. We confirmed the suitability of S-PMA to detect exposures to benzene as low as 0 3 ppm (8 h TWA). This low level is fully due to the high specificity of the S-PMA test. The increased sensitivity achieved by lowering the detection limit led to possible detection of exposure to benzene caused by moderate smoking. Despite the fact that we were able to improve the method of measurement of urinary tt-MA by a more efficient clean up, we also confirmed the conclusions by others that with tt-MA, at best, exposures of over 05 ppm can reliably be detected.'014 The reason for this is that in unexposed people relatively high background concentrations of tt-MA are consistently found.8 0112' This background may possibly be due to consumption of sorbic acid, which is used as a preservative in many foodstuffs.5 There may be a preference for uA-MA over S-PMA as a biomarker for benzene exposures of more than 1 ppm (8 h TWA) as HPLC is easier to operate than gas chromatographymass spectroscopy and in most cases is also more readily available. Due to the rather expensive solid phase extraction, the cost/ sample of analysis of tt-MA is about equal to that of S-PMA. A disadvantage of tt-MA for biological monitoring of exposure to benzene is that its formation is decreased in the event of co-exposure to other aromatic hydrocarbons,22 which may lead to underestimation of benzene exposure. Although we have not yet been able to confirm it, our findings in study 12, where hardly any S-PMA was found in a man treated with high doses of an inducer of the hepatic mixed function oxidase, might indicate that the formation of S-PMA may be influenced by co-exposure as well. 
